Rainer H. Bosselmann - Apr 18, 2025 Form 4 Insider Report for ARGAN INC (AGX)

Role
Director
Signature
/s/ Rainer H. Bosselmann by Beverley M. Bosselmann, Attorney-in-Fact
Stock symbol
AGX
Transactions as of
Apr 18, 2025
Transactions value $
$0
Form type
4
Date filed
4/22/2025, 06:41 PM
Previous filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGX Common Stock Options Exercise $0 +2.28K +1.17% $0.00 197K Apr 18, 2025 Direct F1
transaction AGX Common Stock Options Exercise $0 +13.9K +7.07% $0.00 211K Apr 18, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGX Time-Based Restricted Stock Units Options Exercise $0 -4.17K -100% $0.00 0 Apr 18, 2025 Common Stock 4.17K $0.00 Direct F1
transaction AGX Performance-Based Restricted Stock Units Options Exercise $0 -12.5K -100% $0.00 0 Apr 18, 2025 Common Stock 12.5K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 18, 2022, 4,167 shares of Common Stock became issuable to the Reporting Person on April 18, 2025.
F2 Pursuant to the three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 18, 2022, 25,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 18, 2025. The target number of shares was 12,500.